Log in to your Inderes Free account to see all free content on this page.
Neodynamics
0.998 SEK 0%7 investors are following this company
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Revenue
320K
EBIT %
-28,425 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
NEOD
Daily low / high price
0.998 / 0.998
SEK
Market cap
32.55M SEK
Turnover
15.2K SEK
Volume
15K
Analyst
Claus Thestrup
CEO, Sweden
Latest videos
Financial calendar
General meeting
22.05.2024
Interim report
20.08.2024
Interim report
19.11.2024
Annual report
17.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gryningskust Holding AB | 32.9 % | 32.9 % |
Rentability Sweden AB | 4.0 % | 4.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
NeoDynamics publishes Annual Report 2023
Update on NeoDynamics’ management team
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio